Resmed Inc banner

Resmed Inc
OTC:RSMDF

Watchlist Manager
Resmed Inc Logo
Resmed Inc
OTC:RSMDF
Watchlist
Price: 16.99 USD Market Closed
Market Cap: $25.1B

Wall St Price Targets

RSMDF Price Targets Summary
Resmed Inc

Wall Street analysts forecast RSMDF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RSMDF is 24.89 USD with a low forecast of 16.39 USD and a high forecast of 32.19 USD.

Lowest Forecast
Price Target
16.39 USD
4% Downside
Average Forecast
Price Target
24.89 USD
46% Upside
Highest Forecast
Price Target
32.19 USD
89% Upside
Resmed Inc Competitors:
Price Targets
LEG
Leggett & Platt Inc
10% Upside
SK
Sigdo Koppers SA
6% Upside
TXN
Texas Instruments Inc
-14% Downside

Revenue
Forecast

11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
11% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.

Gross Profit
Forecast

11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
11% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.

Operating Income
Forecast

14% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
14% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 12%.

Pre-Tax Income
Forecast

13% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
13% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.

Net Income
Forecast

14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
14% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 11%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RSMDF's stock price target?
Price Target
24.89 USD

According to Wall Street analysts, the average 1-year price target for RSMDF is 24.89 USD with a low forecast of 16.39 USD and a high forecast of 32.19 USD.

What is the Revenue forecast for Resmed Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 8%.

What is the Gross Profit forecast for Resmed Inc?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 4 years is 10%.

What is the Operating Income forecast for Resmed Inc?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 4 years is 12%.

What is the Pre-Tax Income forecast for Resmed Inc?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.

What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 4 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett